Citation Tools
PDFClinical and epidemiological research
Extended report
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)